Kirkland & Ellis and Weil, Gotshal & Manges advised Apax Partners on the transaction, and Ropes & Gray advised Bain Capital. Funds advised by Apax Partners...
Apax Partners’ Acquisition of Zellis Group
Nippon Steel Corporation’s $14 Billion Acquisition Of United States Steel Corporation
Ropes & Gray LLP acted as legal advisor to NSC, while Milbank LLP and Wachtell, Lipton, Rosen & Katz acted as legal advisors to U. S....
AbbVie’s Acquisition of ImmunoGen
Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie, while Ropes & Gray served as legal advisor to ImmunoGen. AbbVie Inc. (NYSE: ABBV) and...
STERIS’ $540 Million Acquisition of BD’s Surgical Instrumentation Platform
Thompson Hine advises STERIS, and Ropes & Gray advises Becton, Dickinson and Company on the deal. STERIS plc (NYSE: STE) announced that the company has signed...
Insight Partners’ $1.3 Billion Continuation Fund II Formation
Willkie Farr and Gallagher served as legal counsel to Insight Partners, while Ropes & Gray served as legal counsel to HarbourVest and Lexington. Insight Partners announced...
Advent and Warburg Pincus’ Acquisition of BioPharma Solutions from Baxter
Cleary Gottlieb Steen & Hamilton and Ropes & Gray are serving as legal advisor to Advent and Warburg Pincus, while Sullivan & Cromwell is serving as...
H.I.G. Infrastructure’s Acquisition of Tower Engineering Professionals
Ropes & Gray advised H.I.G.Infrastructure on the deal. H.I.G.Infrastructure, an affiliate of H.I.G. Capital, announced the acquisition of Tower Engineering Professionals, Inc. (TEP), a leading full-service provider...
ImmunoGen’s Global Multi-Target License and Option Agreement with Vertex
Ropes & Gray represented ImmunoGen, Inc. on the deal. ImmunoGen, Inc., a leader in the field of antibody-drug conjugates, announced a global, multi-target license and option agreement...
Sanofi’s $2.9 Billion Acquisition of Provention Bio
Ropes & Gray represented Provention Bio, Inc. on the deal. Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced a sales agreement...
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
Redx Pharma’s Merger with Jounce Therapeutics
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
Werfen’s $2 Billion Acquisition of Immucor
Milbank advised Werfen, while Ropes & Gray advised TPG in the transaction. TPG announced the sale of Immucor, Inc. to Werfen for approximately $2 billion, with...